An evaluation of the program will be conducted in a home or office setting with 80 pain management providers (PMPs) such as physicians, NPs, and PAs. The proposed evaluation design is a two-group (intervention and control group), randomized trial with a crossover component. The major hypotheses for the proposed evaluation are: 1) PMPs in the intervention group will show greater gains in knowledge and improvements in attitude (from pre- to post-assessment) than participants in the control group; 2) PMPs in the intervention group will show greater gains in clinical skills as measures than those in the control group; and 3) PMPs in the intervention group will retain changes in knowledge, attitudes and skills over the follow-up period of six to nine weeks.
US Code:
42 USC 191
Name of Law: General Purpose of NIDA
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.